Concepedia

Treatment Progression

Treatment Progression is a methodological framework within the domain of Appliance Adjustment that systematically delineates the chronological stages and criteria for modifying therapeutic interventions based on predefined indicators of clinical improvement or deviation from expected outcomes.

116

Publications

6.7K

Citations

910

Authors

473

Institutions

Publications per year

2017–2026

43

Parents

Publications

116

Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease

Wei Liu, Zhao-Wu Tao, Lei Wang et al. · Chinese Medical Journal · 2020 · 1.2K citations · Full text

, , +16

Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study

Suresh S. Ramalingam, Yi Cheng, C. Zhou et al. · Annals of Oncology · 2018 · 355 citations · Full text

, , +13

Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025

Bernard Escudier, Robert J. Motzer, Padmanee Sharma et al. · European Urology · 2017 · 240 citations

, , +13

Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer

Juliann Chmielecki, Jhanelle E. Gray, Ying Cheng et al. · Nature Communications · 2023 · 239 citations · Full text

, , +17

Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trial

Juliann Chmielecki, Tony Mok, Yi‐Long Wu et al. · Nature Communications · 2023 · 173 citations · Full text

, , +17

1–5 of 116

Authors

910

  1. JC
    Juliann Chmielecki

    Foundation Medicine (United States)

    4 publications · 807 citations

    4

    h-index

  2. MM
    Margarita Majem

    Hospital de Sant Pau, Spain

    3 publications · 634 citations

    3

    h-index

  3. AM
    Aleksandra Markovets

    AstraZeneca (United States), United States

    3 publications · 634 citations

    3

    h-index

  4. JC
    J. Carl Barrett

    National Institute of Environmental Health Sciences, United States

    3 publications · 767 citations

    3

    h-index

  5. FI
    Fumio Imamura

    Osaka International Cancer Institute, Japan

    3 publications · 634 citations

    3

    h-index

1–5 of 910

Institutions

473

  1. Moffitt Cancer Center

    Tampa, United States

    7 h-index

    7 publications

    823 citations

  2. The University of Texas MD Anderson Cancer Center

    Houston, United States

    6 h-index

    11 publications

    1.1K citations

  3. Emory University

    Atlanta, United States

    6 h-index

    6 publications

    867 citations

  4. Princess Margaret Cancer Centre

    Toronto, Canada

    6 h-index

    6 publications

    476 citations

  5. Bristol-Myers Squibb (United States)

    New York, United States

    5 h-index

    15 publications

    1.7K citations

  6. Memorial Sloan Kettering Cancer Center

    New York, United States

    5 h-index

    12 publications

    620 citations

  7. Yonsei University

    Seoul, South Korea

    5 h-index

    7 publications

    982 citations

  8. Dana-Farber Cancer Institute

    Boston, United States

    4 h-index

    20 publications

    511 citations

1–8 of 473

Venues

  1. Journal of Clinical Oncology

    13 publications · 460 citations

    12

    h-index

  2. PubMed

    Repository · 5 publications · 113 citations

    5

    h-index

  3. Annals of Oncology

    3 publications · 428 citations

    3

    h-index

  4. The Oncologist

    3 publications · 167 citations

    3

    h-index

  5. Cancer

    3 publications · 177 citations

    3

    h-index

1–5